Skip to content
MedsAcross

Brand family

Apadaz

Acetaminophen and Benzhydrocodone · Zevra Therapeutics
United States
Presentations
3
Markets
1

Apadaz is a brand of Acetaminophen and Benzhydrocodone marketed by Zevra Therapeutics, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Acetaminophen and Benzhydrocodone
Brand owner
Zevra Therapeutics
Registered in
United States
Strengths and forms
325 mg/4.08 mg tablet, 325 mg/6.12 mg tablet, 325 mg/8.16 mg tablet

All presentations

MedicineManufacturerRegisterAvailability
Apadaz 325 mg/4.08 mg tabletOralZevra TherapeuticsUS FDAAvailable on request
Apadaz 325 mg/6.12 mg tabletOralZevra TherapeuticsUS FDAAvailable on request
Apadaz 325 mg/8.16 mg tabletOralZevra TherapeuticsUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Apadaz

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.